Report Detail

Other Global Cardiac Ablation Market Insights, Forecast to 2025

  • RnM3536253
  • |
  • 17 June, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Other

Cath labs or cardiac catheterization laboratories in hospitals conduct both diagnostic and therapeutic procedures. These laboratories are used to conduct normal procedures such as the monitoring of blood flow and heart pressure. Advances in catheterization technology such as robot-assisted catheterization for cardiac catheterization have advanced the digital imaging system. One driver in market is growing focus on clinical trials. Vendors are using advanced technologies to develop innovative ablation catheters. They invest in R&D to develop cost-effective and efficient devices and lower manufacturing costs. Many of these devices are awaiting approval across different countries.
One of the primary drivers for this market is the rise in the adoption of minimally invasive procedures with improved medical imaging. Medical facilities across the world are shifting toward minimally invasive procedures, which involve the use of radiotherapy and imaging technologies and expand the treatment options for cardiac diseases such as atrial fibrillation. Through imaging, the anatomy of the heart can be studied, which helps the physician diagnose and conduct cardiac ablation procedure. For instance, fluoroscopy imaging is used for most of the complex atrial fibrillation procedures; fluoroscopy imaging modality is used to guide the catheter and improve the surgical outcome. These advantages of medical imaging are expected to propel growth in the global cardiac ablation market during the forecast period.
The emerging markets including China, India, Brazil, and Mexico have become attractive destinations for companies engaged in the development, manufacturing, and distribution of cardiac ablation products. A number of factors such as success of microwave ablation procedure in clinical trials to treat atrial fibrillation, growing adoption of ablation in CVS disease treatment, and growing market penetration of ablation product manufacturers across developing countries are offering high growth opportunities for the players’ active in the Cardiac ablation market.
The global Cardiac Ablation market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cardiac Ablation market based on company, product type, end user and key regions.

This report studies the global market size of Cardiac Ablation in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiac Ablation in these regions.
This research report categorizes the global Cardiac Ablation market by top players/brands, region, type and end user. This report also studies the global Cardiac Ablation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boston Scientific
Medtronic
St. Jude Medical
AblaCor
Advanced Cardiac Therapeutics
AngioDynamics

Market size by Product
Irreversible Electroporation
HIFU
MRgFUS
Market size by End User
Cardiac Arrhythmia
Atrial Fibrillation
Tachycardia
Open Surgery

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Cardiac Ablation market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cardiac Ablation market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cardiac Ablation companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cardiac Ablation submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Cardiac Ablation are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cardiac Ablation market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Cardiac Ablation Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Cardiac Ablation Market Size Growth Rate by Product
      • 1.4.2 Irreversible Electroporation
      • 1.4.3 HIFU
      • 1.4.4 MRgFUS
    • 1.5 Market by End User
      • 1.5.1 Global Cardiac Ablation Market Size Growth Rate by End User
      • 1.5.2 Cardiac Arrhythmia
      • 1.5.3 Atrial Fibrillation
      • 1.5.4 Tachycardia
      • 1.5.5 Open Surgery
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Cardiac Ablation Market Size
      • 2.1.1 Global Cardiac Ablation Revenue 2014-2025
      • 2.1.2 Global Cardiac Ablation Sales 2014-2025
    • 2.2 Cardiac Ablation Growth Rate by Regions
      • 2.2.1 Global Cardiac Ablation Sales by Regions
      • 2.2.2 Global Cardiac Ablation Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Cardiac Ablation Sales by Manufacturers
      • 3.1.1 Cardiac Ablation Sales by Manufacturers
      • 3.1.2 Cardiac Ablation Sales Market Share by Manufacturers
      • 3.1.3 Global Cardiac Ablation Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cardiac Ablation Revenue by Manufacturers
      • 3.2.1 Cardiac Ablation Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cardiac Ablation Revenue Share by Manufacturers (2014-2019)
    • 3.3 Cardiac Ablation Price by Manufacturers
    • 3.4 Cardiac Ablation Manufacturing Base Distribution, Product Types
      • 3.4.1 Cardiac Ablation Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Cardiac Ablation Product Type
      • 3.4.3 Date of International Manufacturers Enter into Cardiac Ablation Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Cardiac Ablation Sales by Product
    • 4.2 Global Cardiac Ablation Revenue by Product
    • 4.3 Cardiac Ablation Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Cardiac Ablation Breakdown Data by End User

    6 North America

    • 6.1 North America Cardiac Ablation by Countries
      • 6.1.1 North America Cardiac Ablation Sales by Countries
      • 6.1.2 North America Cardiac Ablation Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Cardiac Ablation by Product
    • 6.3 North America Cardiac Ablation by End User

    7 Europe

    • 7.1 Europe Cardiac Ablation by Countries
      • 7.1.1 Europe Cardiac Ablation Sales by Countries
      • 7.1.2 Europe Cardiac Ablation Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Cardiac Ablation by Product
    • 7.3 Europe Cardiac Ablation by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Cardiac Ablation by Countries
      • 8.1.1 Asia Pacific Cardiac Ablation Sales by Countries
      • 8.1.2 Asia Pacific Cardiac Ablation Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Cardiac Ablation by Product
    • 8.3 Asia Pacific Cardiac Ablation by End User

    9 Central & South America

    • 9.1 Central & South America Cardiac Ablation by Countries
      • 9.1.1 Central & South America Cardiac Ablation Sales by Countries
      • 9.1.2 Central & South America Cardiac Ablation Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Cardiac Ablation by Product
    • 9.3 Central & South America Cardiac Ablation by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Cardiac Ablation by Countries
      • 10.1.1 Middle East and Africa Cardiac Ablation Sales by Countries
      • 10.1.2 Middle East and Africa Cardiac Ablation Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Cardiac Ablation by Product
    • 10.3 Middle East and Africa Cardiac Ablation by End User

    11 Company Profiles

    • 11.1 Boston Scientific
      • 11.1.1 Boston Scientific Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Boston Scientific Cardiac Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Boston Scientific Cardiac Ablation Products Offered
      • 11.1.5 Boston Scientific Recent Development
    • 11.2 Medtronic
      • 11.2.1 Medtronic Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Medtronic Cardiac Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Medtronic Cardiac Ablation Products Offered
      • 11.2.5 Medtronic Recent Development
    • 11.3 St. Jude Medical
      • 11.3.1 St. Jude Medical Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 St. Jude Medical Cardiac Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 St. Jude Medical Cardiac Ablation Products Offered
      • 11.3.5 St. Jude Medical Recent Development
    • 11.4 AblaCor
      • 11.4.1 AblaCor Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 AblaCor Cardiac Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 AblaCor Cardiac Ablation Products Offered
      • 11.4.5 AblaCor Recent Development
    • 11.5 Advanced Cardiac Therapeutics
      • 11.5.1 Advanced Cardiac Therapeutics Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Advanced Cardiac Therapeutics Cardiac Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Advanced Cardiac Therapeutics Cardiac Ablation Products Offered
      • 11.5.5 Advanced Cardiac Therapeutics Recent Development
    • 11.6 AngioDynamics
      • 11.6.1 AngioDynamics Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 AngioDynamics Cardiac Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 AngioDynamics Cardiac Ablation Products Offered
      • 11.6.5 AngioDynamics Recent Development

    12 Future Forecast

    • 12.1 Cardiac Ablation Market Forecast by Regions
      • 12.1.1 Global Cardiac Ablation Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Cardiac Ablation Revenue Forecast by Regions 2019-2025
    • 12.2 Cardiac Ablation Market Forecast by Product
      • 12.2.1 Global Cardiac Ablation Sales Forecast by Product 2019-2025
      • 12.2.2 Global Cardiac Ablation Revenue Forecast by Product 2019-2025
    • 12.3 Cardiac Ablation Market Forecast by End User
    • 12.4 North America Cardiac Ablation Forecast
    • 12.5 Europe Cardiac Ablation Forecast
    • 12.6 Asia Pacific Cardiac Ablation Forecast
    • 12.7 Central & South America Cardiac Ablation Forecast
    • 12.8 Middle East and Africa Cardiac Ablation Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Cardiac Ablation Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Cardiac Ablation . Industry analysis & Market Report on Cardiac Ablation is a syndicated market report, published as Global Cardiac Ablation Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cardiac Ablation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,866.10
      5,799.15
      7,732.20
      4,508.00
      6,762.00
      9,016.00
      760,333.00
      1,140,499.50
      1,520,666.00
      409,150.00
      613,725.00
      818,300.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report